Medtech Insight
>>Policy & Regulation

OUS Approvals Analysis: Abbott Announces Three Glucose Control CE Marks; iVascular Earns Five Approvals In India

13 Oct 2017

Cardiovascular and diabetes device dominated September's list of medical device approvals from outside the US on Medtech Insight's Approvals Tracker. The 24 non-US approvals in September is below average for 2017, but one more than September of 2016 and keeps 2017 on a track to have about 40% more non-US approvals than 2016.

International Flags Blowing In Wind_1200x675 — • Source: shutterstock.com

[Editors' note: For sortable and searchable tables of all US and non-US approvals and clearances in 2017 and previous years, check out our Approvals Tracker.]

Abbott Laboratories Inc. leads September's list of approvals from outside the US, according to Medtech Insight's Approvals Tracker, with six approvals – all CE Marks for glucose control products....